Evommune EVMN Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's common stock issuance for private placement?
- Evommune (EVMN) reported common stock issuance for private placement of $8M in Q4 2025.
- What does common stock issuance for private placement mean?
- The total cash proceeds received by the company from the sale of equity or debt securities directly to private investors rather than through a public offering. This is a critical liquidity metric for clinical-stage companies that rely on private capital to fund research and development. It highlights the company's ability to secure non-dilutive or private funding to sustain operations.